UroGen Pharma Ltd. Ratios

Ratios Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 99.84%92.65%-59.84%100.00%91.45%89.27%88.11%88.68%90.18%
EBT Margin -11.07%-244.93%-6,696.10%-584,144.44%-1,060.34%-227.66%-167.86%-118.87%-137.22%
EBIT Margin 4.55%-244.55%-6,842.20%-608,211.11%-1,074.15%-192.11%-122.82%-79.23%-107.06%
EBITDA Margin 4.55%-245.16%-6,707.18%-582,611.11%-1,088.98%-231.29%-170.71%-123.47%-140.30%
Operating Margin 4.55%-244.55%-6,842.20%-608,211.11%-1,074.15%-192.11%-122.82%-79.23%-107.06%
Net Margin -11.07%-245.16%-6,707.18%-584,144.44%-1,088.94%-230.67%-170.58%-123.61%-140.35%
FCF Margin 19.93%-120.61%-3,359.40%-396,344.44%-907.71%-178.27%-136.45%-92.57%-107.37%
Efficiency
Inventory Average 0.21M3.40M4.58M5.00M7.45M
Assets Average 49.30M89.55M152.97M162.20M120.88M127.68M156.97M232.01M
Equity Average 42.41M79.30M135.20M138.33M52.38M-40.47M-77.29M-37.01M
Invested Capital 16.31M68.52M90.09M180.30M96.36M8.41M-89.36M-65.21M-8.80M
Asset Utilization Ratio 0.170.010.000.070.400.500.530.39
Leverage & Solvency
Debt to Equity -1.09-1.51-13.83
Debt Ratio 0.720.550.43
Equity Ratio 0.710.910.870.890.790.07-0.66-0.37-0.03
Valuation
Enterprise Value -21.46M411.10M490.56M553.01M296.10M124.08M104.84M326.03M212.74M
Market Capitalization 484.10M592.13M700.09M398.12M213.22M204.81M462.99M449.42M
Return Ratios
Return on Sales -0.11%-2.45%-67.07%-10.89%-2.31%-1.71%-1.24%-1.40%
Return on Capital Employed -0.47%-1.01%-0.82%-0.90%-0.94%-0.76%-0.52%-0.52%
Return on Assets -0.41%-0.84%-0.69%-0.79%-0.92%-0.86%-0.65%-0.55%
Return on Equity -0.47%-0.95%-0.78%-0.93%-2.12%2.71%1.32%3.43%